Details for New Drug Application (NDA): 204977
✉ Email this page to a colleague
The generic ingredient in OMTRYG is omega-3-acid ethyl esters type a. There are thirteen drug master file entries for this compound. Additional details are available on the omega-3-acid ethyl esters type a profile page.
Summary for 204977
Tradename: | OMTRYG |
Applicant: | Osmotica Pharm Us |
Ingredient: | omega-3-acid ethyl esters type a |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 1.2GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | ||||
Approval Date: | Apr 23, 2014 | TE: | RLD: | Yes |
Complete Access Available with Subscription